✦ LIBER ✦

VACCINATION OF HORMONE-REFRACTORY PROSTATE CANCER PATIENTS WITH PEPTIDE COCKTAIL-LOADED DENDRITIC CELLS: RESULTS OF A PHASE I CLINICAL TRIAL

✍ Scribed by S. Füssel; A. Meye; M. Schmitz; S. Zastrow; C. Linné; K. Richter; B. Lobel; O.W. Hakenberg; K. Hoelig; E.P. Rieber; M.P. Wirth

Book ID: 119617286
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 42 KB
Volume: 5
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(06)61307-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VACCINATION OF HORMONE-REFRACTORY PROSTA

VACCINATION OF HORMONE-REFRACTORY PROSTATE CANCER PATIENTS WITH PEPTIDE COCKTAIL-LOADED DENDRITIC CELLS: CLINICAL RESULTS OF A PHASE I CLINICAL TRIAL

✍ O. Hakenberg; S. Fuessel; A. Meye; M. Schmitz; S. Zastrow; K. Richter; P. Rieber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Re: Vaccination of Hormone-Refractory Pr

Re: Vaccination of Hormone-Refractory Prostate Cancer Patients with Peptide Cocktail-Loaded Dendritic Cells: Results of a Phase 1 Clinical Trial

✍ Hans-Peter Schmid 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

VACCINATION OF HORMONE-REFRACTORY PROSTA

VACCINATION OF HORMONE-REFRACTORY PROSTATE CANCER PATIENTS WITH PEPTIDE COCKTAIL-LOADED DENDRITIC CELLS: IMMUNOLOGICAL RESULTS OF A PHASE 1 CLINICAL TRIAL

✍ S. Fuessel; M. Schmitz; K. Richter; A. Meye; S. Zastrow; C. Linné; O.W. Hakenber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

904 INITIAL RESULTS FROM PHASE I/II TRIA

904 INITIAL RESULTS FROM PHASE I/II TRIAL WITH DENDRITIC CELLS LOADED WITH AN ALLOGENEIC PROSTATE CANCER-LYSATE IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS

✍ P. Reyes; M.N. Lopez; C. Pereda; R. Aguilera; F. Salazar-Onfray 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A phase I trial of DNA vaccination with

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

✍ Pavlenko, M; Roos, A-K; Lundqvist, A; Palmborg, A; Miller, A M; Ozenci, V; Bergm 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Infusion of dendritic cells pulsed with

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

✍ Murphy, G.P.; Tjoa, B.A.; Simmons, S.J.; Jarisch, J.; Bowes, V.A.; Ragde, H.; Ro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 2 views

## Background: A phase ii trial was conducted to assess the efficacy of infusions of dendritic cells (dc) and two hla-a2-specific psma peptides (psm-p1 and -p2). this report describes thirty three subjects with hormone-refractory metastatic prostate cancer without prior vaccine therapy history who